170 related articles for article (PubMed ID: 16956910)
1. Expression of haematopoietic stem cell markers, CD133 and CD34 on human corneal keratocytes.
Perrella G; Brusini P; Spelat R; Hossain P; Hopkinson A; Dua HS
Br J Ophthalmol; 2007 Jan; 91(1):94-9. PubMed ID: 16956910
[TBL] [Abstract][Full Text] [Related]
2. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells.
Kobari L; Giarratana MC; Pflumio F; Izac B; Coulombel L; Douay L
J Hematother Stem Cell Res; 2001 Apr; 10(2):273-81. PubMed ID: 11359674
[TBL] [Abstract][Full Text] [Related]
3. [Expression of AC133 vs. CD34 in acute childhood leukemias].
Ebener U; Brinkmann A; Zotova V; Niegemann E; Wehner S
Klin Padiatr; 2000; 212(3):90-8. PubMed ID: 10916777
[TBL] [Abstract][Full Text] [Related]
4. A novel population of repair cells identified in the stroma of the human cornea.
Thill M; Schlagner K; Altenähr S; Ergün S; Faragher RG; Kilic N; Bednarz J; Vohwinkel G; Rogiers X; Hossfeld DK; Richard G; Gehling UM
Stem Cells Dev; 2007 Oct; 16(5):733-45. PubMed ID: 17999595
[TBL] [Abstract][Full Text] [Related]
5. [Studies on the dynamics of biological characteristics of CD133+ cells from human umbilical cord blood during short-term culture].
Hao SG; Sun GL; Wu WL; Wu YL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):569-75. PubMed ID: 14706136
[TBL] [Abstract][Full Text] [Related]
6. Mobilization of human CD34+ CD133+ and CD34+ CD133(-) stem cells in vivo by consumption of an extract from Aphanizomenon flos-aquae--related to modulation of CXCR4 expression by an L-selectin ligand?
Jensen GS; Hart AN; Zaske LA; Drapeau C; Gupta N; Schaeffer DJ; Cruickshank JA
Cardiovasc Revasc Med; 2007; 8(3):189-202. PubMed ID: 17765649
[TBL] [Abstract][Full Text] [Related]
7. Expression, regulation and function of AC133, a putative cell surface marker of primitive human haematopoietic cells.
Majka M; Ratajczak J; Machalinski B; Carter A; Pizzini D; Wasik MA; Gewirtz AM; Ratajczak MZ
Folia Histochem Cytobiol; 2000; 38(2):53-63. PubMed ID: 10833669
[TBL] [Abstract][Full Text] [Related]
8. Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping.
Wuchter C; Ratei R; Spahn G; Schoch C; Harbott J; Schnittger S; Haferlach T; Creutzig U; Sperling C; Karawajew L; Ludwig WD
Haematologica; 2001 Feb; 86(2):154-61. PubMed ID: 11224484
[TBL] [Abstract][Full Text] [Related]
9. Viable CD34+/CD133+ blood progenitor cell dose as a predictor of haematopoietic engraftment in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation.
Hicks C; Wong R; Manoharan A; Kwan YL
Ann Hematol; 2007 Aug; 86(8):591-8. PubMed ID: 17492259
[TBL] [Abstract][Full Text] [Related]
10. Growth factor receptors in hematopoietic stem cells: EPH family expression in CD34+ and CD133+ cell populations from mobilized peripheral blood.
Lazarova P; Wu Q; Kvalheim G; Suo Z; Haakenstad KW; Metodiev K; Nesland JM
Int J Immunopathol Pharmacol; 2006; 19(1):49-56. PubMed ID: 16569339
[TBL] [Abstract][Full Text] [Related]
11. Increased levels of NOTCH1, NF-kappaB, and other interconnected transcription factors characterize primitive sets of hematopoietic stem cells.
Panepucci RA; Oliveira LH; Zanette DL; Viu Carrara Rde C; Araujo AG; Orellana MD; Bonini de Palma PV; Menezes CC; Covas DT; Zago MA
Stem Cells Dev; 2010 Mar; 19(3):321-32. PubMed ID: 19686049
[TBL] [Abstract][Full Text] [Related]
12. CD34+ corneal stromal cells are bone marrow-derived and express hemopoietic stem cell markers.
Sosnová M; Bradl M; Forrester JV
Stem Cells; 2005 Apr; 23(4):507-15. PubMed ID: 15790772
[TBL] [Abstract][Full Text] [Related]
13. Platelet released growth factors boost expansion of bone marrow derived CD34(+) and CD133(+) endothelial progenitor cells for autologous grafting.
Lippross S; Loibl M; Hoppe S; Meury T; Benneker L; Alini M; Verrier S
Platelets; 2011; 22(6):422-32. PubMed ID: 21473675
[TBL] [Abstract][Full Text] [Related]
14. Immunologic purging of autologous peripheral blood stem cell products based on CD34 and CD133 expression can be effectively and safely applied in half of the acute myeloid leukemia patients.
Feller N; van der Pol MA; Waaijman T; Weijers GW; Westra G; Ossenkoppele GJ; Schuurhuis GJ
Clin Cancer Res; 2005 Jul; 11(13):4793-801. PubMed ID: 16000576
[TBL] [Abstract][Full Text] [Related]
15. Highly efficient ex vivo expansion of human hematopoietic stem cells using Delta1-Fc chimeric protein.
Suzuki T; Yokoyama Y; Kumano K; Takanashi M; Kozuma S; Takato T; Nakahata T; Nishikawa M; Sakano S; Kurokawa M; Ogawa S; Chiba S
Stem Cells; 2006 Nov; 24(11):2456-65. PubMed ID: 16857897
[TBL] [Abstract][Full Text] [Related]
16. Identification of surface markers for prospective isolation of human endometrial stromal colony-forming cells.
Schwab KE; Hutchinson P; Gargett CE
Hum Reprod; 2008 Apr; 23(4):934-43. PubMed ID: 18305000
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional profiling reflects shared and unique characters for CD34+ and CD133+ cells.
Hemmoranta H; Hautaniemi S; Niemi J; Nicorici D; Laine J; Yli-Harja O; Partanen J; Jaatinen T
Stem Cells Dev; 2006 Dec; 15(6):839-51. PubMed ID: 17253947
[TBL] [Abstract][Full Text] [Related]
18. Erythropoiesis from adult but not fetal blood-derived CD133+ stem cells depends strongly on interleukin-3.
Böhmer RM
Growth Factors; 2004 Mar; 22(1):45-50. PubMed ID: 15176458
[TBL] [Abstract][Full Text] [Related]
19. Generation of CD133+ cells from CD133- peripheral blood mononuclear cells and their properties.
Suuronen EJ; Wong S; Kapila V; Waghray G; Whitman SC; Mesana TG; Ruel M
Cardiovasc Res; 2006 Apr; 70(1):126-35. PubMed ID: 16530743
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of proliferative potential and clonogenicity of MACS-immunomagnetic isolated CD34+ and CD133+ blood stem cells derived from a single donor.
Freund D; Oswald J; Feldmann S; Ehninger G; Corbeil D; Bornhäuser M
Cell Prolif; 2006 Aug; 39(4):325-32. PubMed ID: 16872366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
